Publication | Closed Access

Identification and development of thiazole leads as COX-2/5-LOX inhibitors through in-vitro and in-vivo biological evaluation for anti-inflammatory activity

InflammationMedicinal ChemistryAnti-inflammatoryNovel TherapyMedicineImmunologyThiazole LeadsPharmacological AgentPharmacotherapyAnti-cancer AgentDrug DevelopmentPharmacologyAnti-inflammatory ActivityDrug DiscoveryCox-2/5-lox Inhibitors